Product Name:Ethyl 5-(chloromethyl)-2,6-dimethylnicotinate
IUPAC Name:ethyl 5-(chloromethyl)-2,6-dimethylpyridine-3-carboxylate
| Packing Unit | Available Stock | Price($) | Quantity |
|---|---|---|---|
| CM177542-1g | 1-2 Weeks | ǟǟŁ |
|
|
|||
| Product Overview |
Ethyl 5-(chloromethyl)-2,6-dimethylnicotinate is a chemical compound that has gained significant attention in the field of medicinal chemistry due to its potential therapeutic applications. This compound is a member of the nicotinic acid ester family and has been studied for its various biological and pharmacological properties. |
| Synthesis and Application |
The synthesis of Ethyl 5-(chloromethyl)-2,6-dimethylnicotinate involves the reaction of nicotinic acid with thionyl chloride, followed by the reaction with ethyl alcohol and chloromethyl methyl ether. The resulting product is then purified through column chromatography to obtain the final compound. This method has been reported to yield high purity and good yield of Ethyl 5-(chloromethyl)-2,6-dimethylnicotinate. Ethyl 5-(chloromethyl)-2,6-dimethylnicotinate has been extensively studied for its potential therapeutic applications. It has been reported to exhibit antitumor, anti-inflammatory, and antimicrobial activities. Several studies have also reported its potential as a drug candidate for the treatment of various diseases such as cancer, Alzheimer's disease, and diabetes. Furthermore, it has been shown to possess antioxidant and neuroprotective properties. |
| Future Directions |
There are several future directions for the research on Ethyl 5-(chloromethyl)-2,6-dimethylnicotinate. One of the areas of interest is the development of more efficient synthesis methods to improve the yield and purity of the compound. Additionally, further studies are needed to understand the mechanism of action and potential side effects of the compound. Furthermore, the potential therapeutic applications of Ethyl 5-(chloromethyl)-2,6-dimethylnicotinate need to be explored further, particularly in the treatment of cancer, Alzheimer's disease, and diabetes. |
Search 
+86 21 5895 0110 
